Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
1,208.12
+80.43 (7.13%)
At close: Jun 26, 2026, 4:00 PM EDT
1,211.00
+2.88 (0.24%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Eli Lilly Revenue by Segment
History
| Date | Cardiometabolic | Oncology | Immunology | Neuroscience | Other |
|---|---|---|---|---|---|
| Mar 31, 2026 | 54.77B | 9.70B | 5.36B | 1.50B | 917.10M |
| Dec 31, 2025 | 48.22B | 9.38B | 5.25B | 1.39B | 943.00M |
| Sep 30, 2025 | 42.84B | 9.32B | 5.00B | 1.32B | 942.20M |
| Jun 30, 2025 | 37.06B | 9.14B | 4.82B | 1.36B | 867.80M |
| Mar 31, 2025 | 33.24B | 8.89B | 4.65B | 1.36B | 873.90M |
| Dec 31, 2024 | 29.52B | 8.75B | 4.39B | 1.47B | 902.90M |
| Sep 30, 2024 | 26.16B | 8.08B | 4.21B | 1.44B | 968.50M |
| Jun 30, 2024 | 23.47B | 7.60B | 4.01B | 2.86B | 981.80M |
| Mar 31, 2024 | 20.97B | 7.11B | 3.85B | 2.91B | 1.09B |
| Dec 31, 2023 | 19.67B | 6.66B | 3.80B | 2.88B | 1.12B |
| Sep 30, 2023 | 17.90B | 6.43B | 3.63B | 2.90B | 1.22B |
| Jun 30, 2023 | 16.84B | 5.97B | 3.51B | 1.51B | 1.69B |
| Mar 31, 2023 | 15.27B | 5.67B | 3.37B | 1.51B | 1.87B |
| Dec 31, 2022 | 14.46B | 5.67B | 3.34B | 1.55B | 3.52B |
| Sep 30, 2022 | 14.12B | 5.42B | 3.37B | 1.63B | 4.70B |
| Jun 30, 2022 | 13.73B | 5.54B | 3.51B | 1.71B | 4.59B |
| Mar 31, 2022 | 13.47B | 5.72B | 3.49B | 1.83B | 4.81B |
| Dec 31, 2021 | 13.19B | 5.74B | 3.36B | 1.90B | 4.13B |
| Sep 30, 2021 | 12.86B | 5.85B | 3.10B | 1.90B | 4.04B |
| Jun 30, 2021 | 12.37B | 5.78B | 2.73B | 1.92B | 3.93B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.